← 產業報告目錄
GLP-1 Agonists Market Size, Share & Trends Analysis Report by Product (Ozempic, Trulicity, Mounjaro, Wegovy, Rybelsus, Saxenda, Victoza, Zepbound, Other Products), by Application (Type 2 Diabetes Mellitus, Obesity), by Route of Administration (Parenteral, Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-30頁數 180報告編號 INSIGHTACE-eae016354b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide GLP-1 Agonists Market stood at USD 43.1 billion in 2024, and is poised to reach USD 260.1 billion by 2034, recording a CAGR of 19.9% from 2025 through 2034.
GLP-1 Agonists encompasses glucagon-like peptide-1 receptor agonists. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GLP-1 Agonists Market Snapshot
Chapter 4. Global GLP-1 Agonists Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global GLP-1 Agonists Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on GLP-1 AGONISTS MARKET Industry Trends
Chapter 5. GLP-1 Agonists Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
5.2.1. Ozempic
5.2.2. Trulicity
5.2.3. Mounjaro
5.2.4. Wegovy
5.2.5. Rybelsus
5.2.6. Saxenda
5.2.7. Victoza
5.2.8. Zepbound
5.2.9. Other Products
Chapter 6. GLP-1 Agonists Market Segmentation 2: By Route of Administration, Estimates & Trend Analysis
6.1. Market Share by Route of Administration, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Route of Administration:
6.2.1. Parenteral
6.2.2. Oral
Chapter 7. GLP-1 Agonists Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Type 2 Diabetes Mellitus
7.2.2. Obesity
Chapter 8. GLP-1 Agonists Market Segmentation 4: By Distribution Channel, Estimates & Trend Analysis
8.1. Market Share by Distribution Channel, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
Chapter 9. GLP-1 Agonists Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global GLP-1 Agonists Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021- 2034
9.2.3. North America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021- 2034
9.2.4. North America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021- 2034
9.2.5. North America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021- 2034
9.3. Europe
9.3.1. Europe GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021- 2034
9.3.3. Europe GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021- 2034
9.3.4. Europe GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021- 2034
9.3.5. Europe GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021- 2034
9.4. Asia Pacific
9.4.1. Asia Pacific GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021- 2034
9.4.3. Asia Pacific GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021- 2034
9.4.4. Asia Pacific GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021- 2034
9.4.5. Asia Pacific GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021- 2034
9.5. Latin America
9.5.1. Latin America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021- 2034
9.5.3. Latin America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021- 2034
9.5.4. Latin America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021- 2034
9.5.5. Latin America GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021- 2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by country, 2021- 2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021- 2034
9.6.3. Middle East & Africa GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021- 2034
9.6.4. Middle East & Africa GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021- 2034
9.6.5. Middle East & Africa GLP-1 Agonists Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021- 2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Eli Lilly and Company
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Sanofi
10.2.3. AstraZeneca
10.2.4. Novo Nordisk
10.2.5. Boehringer Ingelheim
10.2.6. Twist Bioscience Corporation
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們